Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Melanoma Drug Unleashing Immune System in Bristol Breakthrough
Bloomberg
Thursday, May 27, 2010 - 7:47am
tags:
melanoma, Bristol-Myers Squibb, ipilimumab
Pfizer says late-stage heart drug trial successful
Marketwatch
Thursday, May 27, 2010 - 7:46am
tags:
Pfizer, Inspra, heart failure
Novartis ovarian cancer drug filings won't proceed
Marketwatch
Thursday, May 27, 2010 - 7:45am
tags:
ovarian cancer, Novartis, patupilone
Piramal to launch own drug ‘by 2012’
FT.com
Wednesday, May 26, 2010 - 11:55pm
tags:
Piramal Healthcare, Abbott Laboratories, India
Terminating the Pregnant Employee: Novartis Emails Lay Out the Appalling Tale
BNET Pharma
Wednesday, May 26, 2010 - 4:54pm
tags:
Novartis, discrimination, lawsuits, sales reps
Icahn to urge removal of Genzyme CEO from board
Reuters,UK
Wednesday, May 26, 2010 - 4:53pm
tags:
Genzyme, Carl Icahn, Henri Termeer
FDA probing hundreds of complaints with J&J meds
Yahoo/AP
Wednesday, May 26, 2010 - 3:47pm
tags:
JNJ, FDA
FDA Proposal to Publish Drug-Rejection Letters Is Good for Pharma, Even if Pharma Doesn't Agree
BNET Pharma
Wednesday, May 26, 2010 - 3:46pm
tags:
FDA, transparency, warnings
Impax Laboratories inks deal with drug maker IGI
Bizjournals.com
Wednesday, May 26, 2010 - 3:43pm
tags:
partnerships, Impax, IGI
FDA warns on diet drugs Xenical, Alli
Marketwatch
Wednesday, May 26, 2010 - 3:42pm
tags:
FDA, Xenical, warnings, Alli, diet drugs
Roche maintains focus as industry faces cutbacks
Reuters
Wednesday, May 26, 2010 - 11:16am
tags:
Roche, breast cancer
FDA slams Perrigo for metal-tainted tablets
Fierce Pharma
Wednesday, May 26, 2010 - 11:12am
tags:
FDA, warnings, Perrigo Company, generics
Biogen Starts Patient Enrollment
Yahoo/Zacks.com
Wednesday, May 26, 2010 - 11:11am
tags:
Biogen Idec, Abbott Laboratories, Acorda Therapeutics, daclizumab, Avonex, MS
Novartis Rep: It Was The Worst That Could Happen
Pharmalot
Wednesday, May 26, 2010 - 10:11am
tags:
Novartis, discrimination, sales reps
Stem Cell Therapeutics shares blitzed after PhIIb stroke trial fails
Fierce Biotech
Wednesday, May 26, 2010 - 9:58am
tags:
Stem Cell Therapeutics
GTx drops after company says toremifene did not meet goals in preventing prostate cancer
Yahoo/AP
Wednesday, May 26, 2010 - 9:44am
tags:
GTx, toremifene, prostate cancer
Charles River CEO Defends WuXi PharmaTech Purchase
Seeking Alpha
Wednesday, May 26, 2010 - 9:43am
tags:
WuXi PharmaTech, M&A, Charles River Laboratories
AstraZeneca Hires Pfizer Exec To Head Global R&D
Pharmalot
Wednesday, May 26, 2010 - 9:24am
tags:
AstraZeneca, Pfizer, R&D
Pozen pockets $20M from AstraZeneca
Bizjournals.com
Wednesday, May 26, 2010 - 9:23am
tags:
Pozen, AstraZeneca, vivmo, arthritis
Watson sued by Genzyme over generic Renvela plans
Yahoo/AP
Wednesday, May 26, 2010 - 9:00am
tags:
Watson Pharmaceuticals, generics, Genzyme, lawsuits, Renvela

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.